Diabetes Mellitus is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: a Propensity Score-Matched Analysis.
Diabetes mellitus (DM) is associated with elevated cancer risk and poor survival outcome in malignancies. The objective of this study was to evaluate the prognostic value of pre-existing DM in chronic lymphocytic leukemia (CLL). Six hundred and thirty-three subjects with newly-diagnosed CLL between 2007 and 2016 were recruited. Propensity score-matched method was performed to balance baseline characteristics and eliminate possible bias. Univariate and multivariate Cox regression analyses screened the independent risk indicators for time-to-first-treatment (TTFT) and cancer specific survival (CSS) of CLL. Receiver-operator characteristic curves and the corresponding areas under the curve assessed the predictive accuracy of CLL-International Prognostic Index (IPI) together with DM. The results showed that 111 patients had pre-existing DM. In the propensity-matched cohort, DM was correlated with inferior TTFT and CSS in CLL patients, and it was an independent prognostic factor for both CSS and TTFT. Pre-diabetics also shared undesirable prognostic outcome compared with patients with no diabetic tendency, and a positive association between longer diabetic duration and poorer prognosis of CLL was identified. DM as one additional point to CLL-IPI had larger AUC compared with CLL-IPI alone in CSS prediction and could improve the prognostic capacity of CLL-IPI. Pre-existing DM was found to be a valuable prognostic predictor, and could help predict life expectancy and build refined prognostication models for CLL.